| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/19/2007 | WO2006130553A3 Hcv protease inhibitors |
| 07/19/2007 | US20070166276 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 07/19/2007 | CA2636765A1 Cycloalkylcarbonylamino acid ester derivative and process for producing the same |
| 07/19/2007 | CA2636761A1 Cycloalkylcarbonylamino acid derivative and process for producing the same |
| 07/18/2007 | EP1808440A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 07/18/2007 | EP1807443A1 Acylated nonadepsipeptides used as lysobactin derivatives |
| 07/18/2007 | EP1306367B1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 07/18/2007 | CN1326871C Process for the synthesis of perindopril and its pharmaceutically acceptable salts |
| 07/18/2007 | CN1326870C Antibacterial amide macrocycles |
| 07/18/2007 | CN101001870A Peptid-baserte forbindelser |
| 07/17/2007 | US7244814 Variant Tat proteins and methods for use thereof |
| 07/17/2007 | US7244743 Non-peptidic BRS-3 agonists |
| 07/17/2007 | US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244708 Inhibitors of memapsin 2 and use thereof |
| 07/12/2007 | WO2007077201A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | WO2007056593A3 α-HELIX MIMETICS AND METHOD RELATING TO THE TREATMENT OF CANCER STEM CELLS |
| 07/12/2007 | WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 07/12/2007 | WO2006130686A3 Hcv protease inhibitors in combination with food |
| 07/12/2007 | WO2005097184A3 Antibodies against nogo receptor |
| 07/12/2007 | US20070161789 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161575 Inhibiting the replication of hepatitis C virus, therapy, infections |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | US20070161556 Antifungal Therapeutic targets |
| 07/12/2007 | US20070161543 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 07/12/2007 | US20070161542 Ptb1b photoprobes |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/12/2007 | CA2634195A1 Piperazine compounds with a herbicidal action |
| 07/11/2007 | EP1806356A2 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 07/11/2007 | EP1806355A1 Process for production of (1,3-disubstituted indolyl)- urea derivatives, intermediates therefor, and process for production of the intermediates |
| 07/11/2007 | EP1806141A1 Par-2 antagonists |
| 07/11/2007 | EP1805208A2 Labeled compounds for proteasome inhibition |
| 07/11/2007 | EP1805207A1 Treatment of traumatic or degenerative neurologic, otologic, or ophthalmologic diseases with targeted protease inhibitors |
| 07/11/2007 | CN1325511C Glutathion purification and separation method |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | CA2203129C Creating an aerosolized formulation of insulin |
| 07/10/2007 | CA2108466C Hcv genomic sequences for diagnostics and therapeutics |
| 07/05/2007 | WO2007076322A2 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 07/05/2007 | WO2007074185A1 Antimicrobial cyclic peptides |
| 07/05/2007 | WO2007073597A1 Enzyme measurement assay using a modified substrate comprising a substrate attached to a macromolecule via a spacer |
| 07/05/2007 | WO2007030656A8 Ring-closing metathesis process for the preparation of macrocyclic peptides |
| 07/05/2007 | WO2006126198A3 Arts c-terminus fragments and mimetics thereof |
| 07/05/2007 | US20070155803 Protease inhibitors |
| 07/05/2007 | US20070155801 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070155657 Hypoglycemic agent |
| 07/05/2007 | US20070155656 Hypoglycemic agent |
| 07/05/2007 | US20070155655 Zinc (vitamin C)2 complex; low toxicity; insulin mimetics; stability; fat soluble; diabetes |
| 07/05/2007 | US20070154394 Diagnostic agents for pancreatic exocrine function |
| 07/05/2007 | DE102005054700A1 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 07/05/2007 | CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 07/05/2007 | CA2633361A1 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 07/04/2007 | EP1803706A1 HIV protease inhibitors based on amino acid derivatives |
| 07/04/2007 | EP1802649A1 Solid phase peptide sythesis |
| 07/04/2007 | EP1802595A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 07/04/2007 | EP1161449B1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 07/04/2007 | CN1993377A Alanine 2,3,aminomutase |
| 07/04/2007 | CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 07/04/2007 | CN1324008C Novel compounds and compositions as cathepsin inhibitors |
| 07/03/2007 | US7238830 N-alkylaspartyl dipeptide ester compounds |
| 07/03/2007 | US7238341 Peptide-based multimeric targeted contrast agents |
| 06/28/2007 | WO2007071874A2 Novel compounds which interact with pea-15 |
| 06/28/2007 | WO2007071625A2 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 06/28/2007 | WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza |
| 06/28/2007 | US20070149765 Liquid phase peptide syntheses of KL-4 pulmonary surfactant |
| 06/28/2007 | US20070149764 Polypeptide having collagen-like structure |
| 06/28/2007 | US20070149761 To evaluate the effectiveness of a compound to inhibit NS5B activity |
| 06/28/2007 | US20070149460 Modified lysine-mimetic compounds |
| 06/28/2007 | US20070149459 Oxidation of N-[3-amino-1-(cyclobutylmethyl)-2-hydroxy,3-oxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide with an oxidizing agent selected from the group consisting of NaClO, Ca(OCl)2, and NaBrO3 |
| 06/28/2007 | US20070149446 Tamandarin analogs and fragments thereof and methods of making and using |
| 06/28/2007 | CA2633264A1 Novel compounds which interact with pea-15 |
| 06/27/2007 | EP1801115A1 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 06/27/2007 | EP1628995B1 A process for the preparation of perindopril using tetramethyluronium salts as coupling reagents |
| 06/27/2007 | CN1988914A Medical uses of intercellular communication facilitating compounds |
| 06/26/2007 | US7235626 Structured peptide scaffold for displaying turn libraries on phage |
| 06/26/2007 | US7235532 Angiogenic agents and their uses |
| 06/26/2007 | US7235238 Antibodies that bind receptor protein designated 2F1 |
| 06/26/2007 | CA2154445C Lysosomal targeting of immunogens |
| 06/21/2007 | WO2007068053A1 Recombinant protein production |
| 06/21/2007 | US20070142304 Diphenylazetidinone derivatives possessing chloesterol absorption inhibitory activity |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070142300 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 06/21/2007 | US20070142299 Compositions and methods for regulating apoptosis |
| 06/21/2007 | US20070142298 Tetrapeptide lysyl-glutamyl-aspartyl-tryp-tophane |
| 06/21/2007 | US20070142297 New uses for amino acid anticonvulsants |
| 06/21/2007 | US20070142296 D-amino acid peptides |
| 06/21/2007 | US20070142268 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/21/2007 | US20070142267 Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 06/20/2007 | EP1798238A1 Synthetic peptides which reduce or eliminate bags formed under the lower rim of the eyes and use thereof in cosmetic or dermopharmaceutical compositions |
| 06/20/2007 | EP1797119A2 Method of reducing the effects of alpha beta and compositions therefore |
| 06/20/2007 | EP1797111A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/20/2007 | EP1797110A1 Antibacterial amide macrocycles iv |
| 06/20/2007 | EP1623036A4 Identification of novel nogo-receptors and methods related thereto |
| 06/20/2007 | CN1985000A T-cell death-inducing epitopes |
| 06/20/2007 | CN1984922A Substituted prolines as inhibitors of hepatitis c virus NS3 serine protease |